In Case You Missed It
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Celgene shares have been heading higher, but there could still be more upside.
The $5.2 billion takeout of Ariad Pharma was the biggest news from the closely followed healthcare conference.
A selloff in crude oil proves another roadblock in the Dow Jones Industrial Average's pursuit of 20,000.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.